Daily Briefing

The extreme age skew of Covid-19 deaths—even in vaccinated people


While research has shown Covid-19 vaccines significantly reduce the risk of hospitalization and death, elderly, vaccinated people are still at higher risk of dying from the disease than younger, unvaccinated people, David Wallace-Wells writes for New York Magazine's "Intelligencer."

Your top resources for Covid-19 readiness

Covid-19 is far more lethal in older individuals, research shows

Data has long shown that Covid-19 more severely affects the elderly than it does younger people. According to Wallace-Wells, for every five to eight years of age, an unvaccinated individual's chances of dying from Covid-19 roughly double—meaning that advanced age poses a greater risk than even the most significant comorbidities.

The good news is that, across all age groups, vaccines greatly reduce the risk of severe Covid-19. A recent CDC study from Los Angeles, for instance, found that Covid-19 vaccines led to a 29-fold drop in hospitalization risk, and another CDC study suggested the vaccines led to an 11-fold drop in overall mortality risk.

But breakthrough cases do happen—and although most such cases are mild, their risks are far greater for elderly patients. According to CDC data, 70% of breakthrough cases resulting in hospitalization and 87% of those ending in death were among patients over the age of 65. And in England, the median age of patients who died from a breakthrough infection was 84.

This suggests that "in assessing an individual's risk of dying from Covid, age appears still as important—and maybe even more important—than vaccination status," Wallace-Wells writes.

Just how high are breakthrough infection risks in older patients?

According to an analysis of data from England conducted by the Financial Times, an 80-year-old vaccinated against Covid-19 has roughly the same mortality risk as an unvaccinated 50-year-old, Wallace-Wells writes. Even a vaccinated 45-year-old has a higher risk of death from Covid-19 than an unvaccinated 30-year-old.

On the other hand, young children—many of whom are not yet eligible for vaccination—experience relatively low mortality risk from Covid-19, Wallace-Wells writes.

According to recent data from the United Kingdom, an unvaccinated 10-year-old faces a lower risk of death from Covid-19 than a vaccinated 25-year-old. And in England, hospitalization rates among unvaccinated children were found to be lower than those for vaccinated people ages 18 to 29.

calendar
Webinar series: 'Stay Up to Date' on the latest with Covid-19

As a result, an unvaccinated person over the age of 85 is more than 10,000 times more likely to die from Covid-19 than an unvaccinated child under the age of 10, Wallace-Wells writes.

Could booster shots diminish the Covid-19 age skew?

Research has found that immunity from the Covid-19 vaccines wanes over time, especially among the elderly. Because this population already faces disproportionate risks from Covid-19, boosters to restore their immunity could play a powerful role in reducing deaths, Wallace-Wells writes.

According to Wallace-Wells, "the social impact of elevating protection among the most vulnerable by even a few percentage points would be absolutely enormous," given the age skew of Covid-19 mortality risk. "That's because if vulnerability is hundreds of times higher in one group than another, the impact of that boost is going to be much, much larger too," Wallace-Wells writes.

When talking about booster shots, "it simply doesn't make sense to talk about vaccinated 15-year-olds and 95-year-olds in the same breath and unvaccinated 15-year-olds and unvaccinated 95-year-olds in a different breath," Wallace-Wells argues.

Doing so "distorts the picture of the pandemic as a whole" because "a vaccinated 95-year-old is still probably over a thousand times more at risk of death, all else being equal, than an unvaccinated 15-year-old. Which means we probably shouldn't be giving those two groups the same advice about masks or social distancing or boosters." (Wallace-Wells, "Intelligencer," New York Magazine, 9/27)


Your top resources for Covid-19 readiness

Access our resource library

researchLearn from the top health plan resources on how to safely manage and prevent the spread of Covid-19 with our library of research on topics from provider network support to payer strategic outlook. 


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 2 resources each month, including the latest research and webinars.

Want access without creating an account?

   

You have 2 free members-only resources remaining this month remaining this month.

1 free members-only resources remaining this month

1 free members-only resources remaining this month

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.